Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 179,472,067
- Total 13F value
- $9,720,162,187
- Share change
- -4,698,076
- Put/Call ratio
- 65%
- SEC-reported price per share
- $54.16
- Number of holders
- 572
- Value change
- -$257,275,980
- Number of buys
- 295
- Number of sells
- 271
- Shares outstanding
- 192,632,743
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
572
Top holders
10
BMRN full security history
Ownership snapshot
Full 13F holder table
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 8.2%
13D/G row: PRIMECAP MANAGEMENT CO/CA/
Showing 1-6 of 15 holder rows.
Quick read
PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 8.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership
Top 5
PRIMECAP MANAGEMENT CO/CA/
8.2%
Capital Research Global Investors
4.8%
VIKING GLOBAL INVESTORS LP
4.3%
BlackRock, Inc.
12%
VANGUARD GROUP INC
9.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
13F
Company
|
8.2%
|
$906,812,938
15,795,383 shares
|
$0 | 30 Jun 2025 |
| Capital Research Global Investors |
13D/G
13F
Company
|
4.8%
|
$576,308,252
9,150,655 shares
|
-$241,913,549 | 31 Mar 2025 |
| VIKING GLOBAL INVESTORS LP |
13F
13D/G
Company
|
4.3%
from 13D/G
|
$675,504,947
12,288,611 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
12%
|
$1,319,372,049
24,001,675 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.9%
|
$1,044,640,645
19,003,832 shares
|
— | 30 Jun 2025 |
| DODGE & COX |
13F
Company
|
7.8%
|
$830,503,801
15,108,310 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
572
Shares
179,472,067
Rows available
572
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
576
Q3 2025 holders
572
Holder diff
-4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|